PAR 1.64% 31.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-228

  1. 118 Posts.
    lightbulb Created with Sketch. 14
    I mentioned PAR to a respected boutique fund manager about 6 months ago. The first question was "at what stage are they at with trials and approvals?". A successful Phase 3 was a mandatory criterion before they would consider (but I hoped he took a look in any case - the SP of the one he recommended I take a look at in response has gone backwards!). So yes - this was confirmation for me that Phase 3 success in OA will put us in a new league as far as fund management industry.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.005(1.64%)
Mkt cap ! $108.4M
Open High Low Value Volume
31.5¢ 31.5¢ 29.5¢ $98.05K 323.7K

Buyers (Bids)

No. Vol. Price($)
1 29159 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.